MINNEAPOLIS and BRISBANE, Australia, Sept. 19, 2025 (GLOBE NEWSWIRE) — Anteris Technologies Global Corp. (Anteris  or the Company ) (NASDAQ:

You might also be interested in reading P3 Health Partners outlines $120M–$170M EBITDA improvement opportunity for 2026 while strengthening payer contracts.